Our previous studies with estrogen receptor ␤ knockout (ER␤ ؊/؊ ) mice demonstrated that ER␤ is necessary for embryonic development of the brain as early as embryonic day 14.5 (E14.5) and is involved in neuronal migration. Such early effects of ER were unexpected because estradiol synthesis and action in the brain occur at E18.5. In the present study, we examined the distribution of ER␤ in the developing brain and identified a population of ER␤-regulated interneurons. ER␤ appears in the brain at E12.5, mainly localized in the wall of the midbrain, neuromere, hypothalamus, thalamus, and basal plate of pons. At E15.5 and E16.5, ER␤ expression increased in the hypothalamus, thalamus, and midbrain and appeared in the limbic forebrain. At E18.5, ER␤ expression was strongly expressed throughout the brain, including the cerebellum and striatum, whereas there were very few positive cells in the ventricular region. In the paraventricular thalamic nucleus and parafascicular nucleus, most of the calretinin-immunopositive interneurons expressed ER␤. In ER␤ ؊/؊ mice, calretinin expression was markedly lower than in WT mice in the hippocampus, thalamus, and amygdala both at E16.5 and at E18.5. Epidermal growth factor receptor expression was lower in the cortex of ER␤ ؊/؊ than in WT mice at E15.5 and, unlike WT mice, was absent from the superficial marginal zone. These findings suggest that ER␤ in the embryonic brain is necessary for the development of calretininimmunoreactive GABAergic interneurons and for neuronal migration in the cortex through modulating epidermal growth factor receptor expression at middle and later embryonic stages.
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cortex ͉ EGF receptor ͉ striatum ͉ thalamus E strogen is important during brain development, influencing the maturation of neural systems and affecting the sexual differentiation of brain structures and functions (1, 2) . Sexual differentiation in the brain occurs in male rodents at day 18.5 when aromatase is induced in the brain and catalyses the synthesis of estradiol from testosterone secreted from the embryonic testis. At this time, estrogen imprints the neuroendocrine control of gonadal function, reproductive behavior, and the sexual differences in the secretion of growth hormone.
Estrogen actions now are recognized to occur via two distinct estrogen receptors (ER), ER␣ and ER␤, that reside in cell nuclei (3, 4) . In the brain, ER␣ plays a critical role in regulating reproductive neuroendocrine function, whereas ER␤ may be more important in regulating nonreproductive functions (5) (6) (7) (8) . In ER␣ knockout mice, no gross brain abnormalities have been reported, whereas ER␤ plays a prominent role during embryogenesis and there are significant morphological abnormalities in the embryonic brains of ER␤ knockout (ER␤ Ϫ/Ϫ ) mice (9) . Studies have revealed that ER␤ also is expressed in fetal human brain and may mediate effects of estrogen in the developing nervous system (10). Lemmen et al. (11) reported that ER␤ mRNA is detectable in brains of mouse embryo at embryonic day 10.5 (E10.5), but there is no information on the distribution of ER␤ protein in the embryonic brain.
Our previous studies showed that the brains of ER␤ Ϫ/Ϫ mice at E18.5 were smaller than those of their WT and heterozygous littermates. Histological analysis of ER␤ Ϫ/Ϫ mice at E18.5 revealed significant neuronal loss in cortex, thalamus, hypothalamus, amygdala, and ventral tegmental area. Little is known, however, about either the mechanisms or kinds of neurons that are lost in the specific brain regions.
Epidemiological studies suggest that, in women, reduced estrogen levels contribute to depression, sleep disturbance, irritability, anxiety, panic disorders, and cognitive dysfunction (12) (13) (14) (15) . ER␤ Ϫ/Ϫ mice have provided evidence for a role of ER␤ in emotional behavior, including depression, anxiety, and aggression (16) (17) (18) . Although the exact mode of action by which ER␤ exerts its effects in the brain is not clear, it is very likely that the inhibitory neurotransmitter ␥-aminobutyric acid (GABA) is involved (19) (20) (21) . Disruption of GABAergic interneuron development during the embryonic and early postnatal periods can have profound neurological and behavioral consequences, including an increased susceptibility to seizures, heightened anxiety, and diminished social interaction (22) (23) (24) . We have demonstrated that in the absence of ER␤, spatial learning is impaired, and treatment with kainic acid causes marked apoptosis in the hippocampus at doses that do not affect WT littermates (25) . Thus, absence of ER␤ results in a behavioral phenotype similar to the dysfunctions seen upon disruption of GABAergic interneurons.
In the present study, we demonstrate ER␤ expression in the brain during embryogenesis and use ER␤ Ϫ/Ϫ mouse embryos to explore a role of ER␤ in GABAergic interneuron development. Furthermore, we show that ER␤ modulates expression of epidermal growth factor receptor (EGFR). Because EGFR has been demonstrated to promote radial migration in dorsal cortex, influencing neurons settling predominantly in deep layers of the cortical plate and the marginal zone (26, 27) , this may be a mechanism through which ER␤ might regulate migration of cortical neurons of the upper laminae during prenatal life.
Results

ER␤ Expression in the Embryonic Mouse
Brain. ER␤ expression appeared in the embryonic brain at E12.5, and, at this time, most of ER␤ immunoreactive cells were specifically localized in the wall of the midbrain (Fig. 1 A-C) , neuromere (Fig. 1D) , and vestibulocochlear ganglion complex. Some positive nuclei were seen in the hypothalamus ( Fig. 1 E and F) , thalamus, and basal plate of pons (Fig. 1G ), but other regions were negative.
At E15.5 and E16.5, ER␤ expression in the brain increased moderately. There was strong expression in the midbrain, thalamus ( Fig. 2A) , and hypothalamus (Fig. 2B ). Some scattered positive neurons appeared in the striatum (Fig. 2C) . At this stage, ER␤ appeared in the limbic forebrain, including the olfactory bulb ( Fig.  2D) , hippocampus, and amygdala region. Positive nuclei were detected in the deep layer but not in the superficial layer of the cerebral cortex (Fig. 2E ). In the cerebellum, some scattered ER␤-positive nuclei were present (Fig. 2F ). ER␤ expression increased significantly in the brain at E18.5. Strong ER␤ expression was widely distributed in the brain. Coronal sections showed robust nuclear staining in the thalamus (Fig. 3A) and hypothalamus ( Fig. 3B) , and sagittal sections showed strong signals in the wall of the midbrain, pons, and medulla oblongata (Fig. 3C ). In the neocortex, ER␤-positive nuclei were localized mainly in the deep layer, but there also was scattered nuclear staining in the upper layer (Fig. 3D) . Furthermore, increased ER␤ expression appeared in the cerebellum (Fig. 3E) , striatum ( Fig. 3F) , and the olfactory bulb, where positive cells were present in the plexiform layer and mitral cell layer (Fig. 3G ). In the hippocampus, there were strongly labeled nuclei in the dentate gyrus and pyramidal cellular layer (Fig.  3H ). ER␤-positive cells were very rare in the proliferating subventricular region.
Calretinin Expression in the Brain at E18.5 and ER␤ and Calretinin
Colocalization in the Paraventricular Thalamic Nucleus and Parafascicular Nucleus. Calretinin expression was significant in the brain during embryogenesis. At E18.5, in coronal sections, densely packed and strongly stained calretinin-positive cells were localized mainly in the thalamus, including the anterior thalamic nucleus and paraventricular thalamic nucleus (Fig. 4A ), habenular nucleus, reticular nucleus, bed nucleus of mediodorsal stria terminalis (Fig. 4B ), parafascicular nucleus, and reuniens nucleus (Fig. 4C ). Robust expression also was detected in the hippocampal dentate gyrus, lateral hypothalamic area, and basomedial amygdaloid nucleus. Furthermore, there was strong fiber staining in the upper migrating streams, including those from the parafascicular nucleus to either the lateral posterior thalamic nucleus or pretectal area and in the downward migrating streams, including those from the parafascicular nucleus to either the lateral hypothalamic area or the basomedial amygdaloid nucleus (Fig. 4C) . Double staining showed that in the paraventricular thalamic nucleus (Fig. 4 D-F) and parafascicular nucleus most of the calretinin-positive cells also expressed ER␤.
Calretinin Expression in ER␤ ؊/؊ Mice at E16.5 and E18.5. At E16.5, calretinin expression in the parafascicular nucleus, dentate gyrus, and amygdala region of ER␤ Ϫ/Ϫ mice was lower than in WT littermates (Fig. 5 A-D) . In ER␤ Ϫ/Ϫ mice, migrating streams from the parafascicular nucleus to either the pretectal area or the amygdala region were significantly attenuated ( Fig. 5 B and D) . At E18.5, compared with WT mice, in ER␤ Ϫ/Ϫ mice there was reduced calretinin expression in most of the thalamic nuclei, especially in the anterior thalamic nucleus and paraventricular thalamic nucleus, habenular nucleus, reticular nucleus, and parafascicular nucleus. Calretinin expression also was decreased in the dentate gyrus, hypothalamus, and amygdala region (Fig.  5 E-M) .
Expression of EGFR in the Cortex of ER␤ ؊/؊ Mice at E15.5. Several observations have implicated EGFR in the control of neuronal migration in the developing telencephalon and pointed to its importance for the migration of cells from proliferative zones (28) . Within the dorsal cortex of WT mice at E15.5, there was strong EGFR expression localized in two stripes, corresponding to subplate/white matter and the superficial marginal zone (Fig.  6A) . In ER␤ Ϫ/Ϫ mice, EGFR expression was significantly decreased, and, remarkably, there was no EGFR staining in the superficial marginal zone (Fig. 6B) .
Discussion
In this study, we demonstrated that ER␤ is expressed in the brain as early as E12.5, a developmental stage at which the primordia of most CNS structures already are established (29) . Strong and clear nuclear staining was localized in the wall of the midbrain. Robust ER␤ expression in the midbrain also was noticed both at E15.5 and E18.5. We previously have shown that the midbrains of ER␤ Ϫ/Ϫ mice are smaller than those of WT littermates at E18.5. The present results suggest that ER␤ affects neural development in the midbrain during embryogenesis. Consistent with these results, it has been demonstrated that ER␤ is the predominant ER in dopaminergic neurons of the substantia nigra, an important structure in the midbrain (7) , and that estrogen protects dopaminergic neurons from injury (30) (31) (32) (33) .
At E15.5, there was strong ER␤ expression in the hypothalamus, thalamus, and midbrain. The strong expression of ER␤ in the limbic forebrain, including the olfactory bulb, hippocampus, and amygdala region, at E18.5 suggests a role for ER␤ in cognition, mood, and motor functions. In the human brain, ER␤ mRNA has been reported to show a preferential limbic-related expression pattern, including the hippocampal formation, entorhinal cortex, and thalamus (34, 35) .
Although strong ER␤ expression was seen throughout the brain at E18.5, very few positive cells were found in the proliferating subventricular region. A study in rats showed that ER␣ mRNA in the cortex was extensively expressed in the ventricular zone, primitive plexiform layer, and immature cortical plate at least as early as E16 (36) . Thus, it appears that ER␣ and ER␤ are distributed in different spatial and temporal expression patterns in the embryonic brain. If ER␣ indeed is expressed in the subventricular zone, it could be playing a role in proliferation, whereas, conversely, the distribution of ER␤ suggests that this ER isoform plays a role in differentiation and maturation.
GABAergic interneurons are central to the regulation of cerebral intrinsic activity through their direct inhibitory effects on excitatory neurons. Defects in GABAergic function, through either alterations in presynaptic GABA levels or postsynaptic response at GABA receptors, lead to an imbalance in inhibitory and excitatory circuits, which can cause epilepsy and affect the development and function of neural systems underlying cognition and memory (37) (38) (39) (40) (41) . Behavioral studies have revealed that ER␤ Ϫ/Ϫ females are more anxious than their WT littermates in the open field and the elevated plus maze tests, and that there is disrupted GABAergic function in the medial amygdala in these ER␤ Ϫ/Ϫ mice (42) . All of these data are supportive evidence for a relationship between ER␤ and GABAergic interneurons, especially in affecting mood and behavior. In the present study, at E16.5 and E18.5, densely packed, strongly calretinin-immunoreactive cells were found in the mouse thalamic nuclei, lateral hypothalamic area, dentate gyrus, and basomedial amygdaloid nucleus. The pattern of distribution of calretinin suggests that calretinin interneurons may participate in various subcortical and cortical thalamic systems involved in the modulation of emotional and motivational states. Double immunolabeling with ER␤ and calretinin antibodies showed that the majority of calretinin-expressing neurons in the paraventricular thalamic nucleus and parafascicular nucleus also express ER␤. Furthermore, at E16.5 and at E18.5 in ER␤ Ϫ/Ϫ mice, calretinin expression was significantly lower than in WT littermates in the thalamic nuclei, dentate gyrus, and amygdala region. Thus, loss of interneurons may explain some of the neuronal loss that has been observed during brain development in ER␤ Ϫ/Ϫ mice. Further studies should elucidate the mechanism through which ER␤ modulates calretinin interneuron development.
Our previous studies showed that migration of postmitotic neurons to superficial cortical layers is retarded at later embryonic stages in ER␤ Ϫ/Ϫ mice (43) . In the present study, we demonstrate that ER␤ is expressed in the cortex of the embryonic brain from E15.5. At this stage, in the brains of WT mice, EGFR expression was localized in two stripes, corresponding to subplate/white matter and the superficial marginal zone. In ER␤ Ϫ/Ϫ mice, EGFR expression was significantly decreased and especially lost in the superficial marginal zone. Several observations have implicated EGFR in the control of migration in the developing telencephalon and in migration of cells from proliferative zones. Our results can mean either that, in ER␤ Ϫ/Ϫ mice, EGFR-positive neurons failed to reach the superficial marginal zone at later stages of embryonic development or that ER␤, through modulation of EGFR expression, affects migration of postmitotic neurons to superficial cortical layers.
Estradiol synthesis occurs in the developing brain at E18.5 and at this time is responsible for sexual imprinting of the brain (44) . The present studies reveal expression of a functional ER␤ from E12.5, a time when estradiol is not synthesized in the brain and when the brain is protected from maternal estrogen by its sequestration on alpha-fetoprotein (45) . At present, it is not clear how ER␤ is activated in the early embryonic brain. The estrogenic metabolites of dihydrotestosterone [5␣-androstane-3␤,17␤-diol (46)] or of dehydroepiandrosterone [5-androstenediol (47) ] may be more biologically important estrogens than estradiol in the developing brain. Further studies are needed to define how ER␤, expressed in the embryonic brain, is activated and it how inf luences brain function throughout life.
Materials and Methods Animals and Tissue Preparation. ER␤
Ϫ/Ϫ mice were generated as described in ref. 9 . Heterozygous mice were used for breeding. ER␤ ϩ/Ϫ female mice were mated overnight with ER␤ ϩ/Ϫ males and inspected at 9:00 a.m. on the following day for the presence of vaginal plug. Noon of this day was assumed to correspond to E0.5. All animals were housed in the Karolinska University Hospital Animal Facility (Huddinge, Sweden) in a controlled environment on a 12-h light/12-h dark illumination schedule and fed a standard pellet diet with water provided ad libitum. To obtain embryos, pregnant mice were anesthetized deeply with CO 2 and perfused with PBS followed by 4% paraformaldehyde (in 0.1 M PBS, pH 7.4). Embryos were taken out and put on ice, and heads or brains were dissected and postfixed in the same fixative overnight at 4°C. Sex was determined after direct visual inspection of the gonads with a dissecting microscope, and the tail and limbs were removed from each embryo for genotyping.
Both male and female embryos were used, and there were no observable differences between them in our experiments. After fixation, brains were processed for (6-m) paraffin sections. All animal experiments were approved by Stockholm's Södra För-söksdjursetiska Nämnd.
Immunohistochemistry. Paraffin sections were deparaffinized in xylene, rehydrated through graded alcohol, and processed for antigen retrieval by boiling in 10 mM citrate buffer (pH 6.0) for 2 min. The sections were incubated in 0.5% H 2 O 2 in PBS for 30 min at room temperature to quench endogenous peroxidase and then incubated in 0.5% Triton X-100 in PBS for 30 min. To block nonspecific binding, sections were incubated in 3% BSA for 1 h at 4°C. For ER␤ staining, retrieval was improved by incubating the sections with 0.15 units/ml of ␤-galactosidase for 1 h. Sections then were incubated with 1:100 anti-ER␤ 1:100 anti-EGFR and 1:2,000 anti-calretinin in 1% BSA and 0.1% Triton 100 for 48 h at 4°C. BSA replaced primary antibodies in negative controls. After washing, sections were incubated with the corresponding secondary antibodies in 1:200 dilutions for 2 h at room temperature. The Vectastain ABC kit (Vector Laboratories, Burlingame, CA) was used for the avidin-biotin complex (ABC) method according to the manufacturer's instructions. Peroxidase activity was visualized with 3,3-diaminobenzidine (Dako, Glostrup, Denmark). The sections were lightly counterstained with hematoxylin or DAPI, dehydrated through an ethanol series to xylene, and mounted. For immunofluorescence, slides were directly mounted in Vectashield antifading medium (Vector Laboratories). The sections were examined under a Zeiss (Thornwood, NY) fluorescence microscope with filters suitable for selectively detecting the fluorescence of FITC (green) and Cy3 (red) or under a light microscope. For colocalization, images from the same section but showing different antigen signals were overlaid.
Data Analysis. Stained brain sections (10-12 sections per area for each mouse) were examined under a light microscope, and images were captured under ϫ20 magnification. Calretininimmunopositive cells were counted manually on the captured images by using a 200 ϫ 200-m template. Estimates of the number of calretinin-immunoreactive cells per region were made based on the counts of the 10 images showing the highest number of labeled nuclei. Statistical analysis was performed by using Student's t test.
Chemicals and Antibodies. We purchased ␤-galactosidase from Sigma-Aldrich (St. Louis, MO). Rabbit polyclonal anticalretinin from Swant (Bellinzona, Switzerland) and goat polyclonal anti-EGFR from Santa Cruz Biotechnology (Santa Cruz, CA) were used. The chicken polyclonal anti-ER␤ 503 was produced in our laboratory (48); Cy3 anti-chicken, Cy3 anti-goat, and FITC anti-rabbit antibodies were from Jackson ImmunoResearch (West Grove, PA); and biotinylated goat anti-rabbit IgG and rabbit anti-chicken/turkey IgG were from Zymed (South San Francisco, CA).
